Pharma player Dishman Pharma is looking to cut its debt of Rs 100 crore in FY13. JR Vyas, managing director, Dishman Pharma told CNBC-TV18 that the company would be selling its SEZ land to repay debt.
first published: Jul 3, 2012 12:20 pm
A collection of the most-viewed Moneycontrol videos.

Live: Nifty slips below 24,800 as breadth weakens; SMIDs underperform | Closing Bell

Live: Nifty eyes broader market volatility, FOMC outcome for next cues | Opening Bell

Live: Nifty recovers 100 pts from day's lows in a choppy session; smallcaps shine | Closing Bell

Live: Can Nifty reclaim 26,000 after RS 7.5 lakh crore selloff? | IndiGo in focus | Opening Bell
You are already a Moneycontrol Pro user.

